Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2001
12/05/2001CN1325377A New esters derived from substituted phenyl-cyclohexyl compounds
12/05/2001CN1325376A Novel compounds and medicinal use thereof
12/05/2001CN1325309A Compounds, compositions and method for treating or preventing viral infections and associated diseases
12/05/2001CN1325308A Use of neurotrophic factor stimulators for treatment of ophthalmic neurodegenerative diseases
12/05/2001CN1325307A Remedies for spinal canal stenosis
12/05/2001CN1325306A Pharmaceutical moxifloxacin preparation
12/05/2001CN1325305A Method of administering camptothecin compounds for the treatment of cancer with reduced side effects
12/05/2001CN1325304A 5HT1 receptor agonists and metoclopramide for treatment of migraine
12/05/2001CN1325303A Tocopherols, tocotrienols, other chroman and side chain derivatives and uses
12/05/2001CN1325302A Use of dialkylfumarates
12/05/2001CN1325301A Controlled delivery of active agents
12/05/2001CN1325300A Pharmaceutical formulation comprising omeprazole
12/05/2001CN1325299A Orally administered controlled drug delivery system providing temporal and spatial control
12/05/2001CN1325297A Cosmetic composition
12/05/2001CN1325291A Anti-inflammatory and antimicrobial uses for bioactive glass compositions
12/05/2001CN1325284A Method for improved imaging and photodynamic therapy
12/05/2001CN1325270A Antimicrobial composition comprising an oxidoreductase and an enhancing agent of the N-hydroxy anilide-type
12/05/2001CN1325266A Disposable premoistened wipe containing an antimicrobial protease inhibitor
12/05/2001CN1324802A Anti-pregnancy hormone active steroid with fluorated 17 alpha-alkyl-chain
12/05/2001CN1324653A Health food capable of regulating blood lipoid and delaying senility
12/05/2001CN1324638A External-use medicine for treating vaginitis
12/05/2001CN1324629A Gastropathy treating medicine and its prepn.
12/05/2001CN1324622A Bone-strengthening and pus-drawing out ointment
12/05/2001CN1324619A Health capsule of pure active chitosan and animal fiber
12/05/2001CN1324618A Pharmaceutical use of benzoic acid derivatives
12/05/2001CN1324617A Medicine for treating hyperosteogeny and protrusion of lumber intervertebral disc
12/05/2001CN1324616A Medicine for treating rheumatism and rheumatoid disease
12/05/2001CN1324615A Medicine for treating lupus erythematosus
12/05/2001CN1324614A Medicine for treating femoral head necrosis
12/05/2001CN1324613A Use of taxiol stabilized by albumin in preparing emdicine for treating body tumor and medicine obtained therefrom
12/05/2001CN1324612A Medicine for delaying chronic kidney hypofunction
12/05/2001CN1324607A Anti-fungus agent for local treatment of fungus infection of finger and its peripheral tissue and controllable releasable system of keratin-dissolving agnt
12/05/2001CN1324606A Molecule implanting needle and acupoint medicine
12/05/2001CN1075816C Methods for in vivo reduction of nitric oxide levels and compositions sueful therefor
12/05/2001CN1075812C Prodrugs of morpholine tachykinin receptor antagonists
12/05/2001CN1075811C Substituted 2,4-thiazolindione derivative, its preparation method and medicinal composition containing same
12/05/2001CN1075809C Novel vitamin D analogues
12/05/2001CN1075802C Asiatic acid derivatives having modified A-ring
12/05/2001CN1075737C Method for the provocation of air passage narrowing and/or the induction of sputum
12/05/2001CN1075733C Face-nourishing oral liquor and its preparation method
12/05/2001CN1075728C Antiphlogistic healing ointment for curing surgical infection
12/05/2001CN1075723C Medicine for treating angiocardiopathy
12/05/2001CN1075722C Fungicidal compositions containing bifonazole
12/05/2001CN1075721C S-alkyl-DL-homocysteine-S,R-sulfinyl imine medicine
12/04/2001US6326510 Skin disorders; anticancer agents
12/04/2001US6326507 Therapeutic compounds and methods of use
12/04/2001US6326500 Imidazole derivatives for blocking the release of arachidonic acid from phospholipids
12/04/2001US6326499 Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for the treatment of dry eye
12/04/2001US6326495 Heating a mixture of caprolactone and p-methoxybenzylamine; cyclization
12/04/2001US6326490 Antiproliferation agents or anticarcinogenic agents
12/04/2001US6326488 Synthetic oligonucleotide; for as a therapeutic tool in treatment of cancers
12/04/2001US6326476 Oxidation of bovine heparin using periodate, depolymerization, reduction, fractionation and accumulation
12/04/2001US6326475 Dry acid-chitosan complexes
12/04/2001US6326464 Genetically engineered tumor suppressor protein; for use in the treatment of cancers; antiproliferative agents
12/04/2001US6326406 Heating aqueous solution containing lecithin and bile acid salt
12/04/2001US6326405 Using a cyclopentenone compound
12/04/2001US6326404 Use of O-desmethyl-N-mono-desmethyl-tramadol
12/04/2001US6326403 Cardiovascular disorders
12/04/2001US6326402 Aromatic ester compound
12/04/2001US6326401 Formulation for the oromucosal, in particular pernasal, route
12/04/2001US6326398 Oxamic acids and derivatives as thyroid receptor ligands
12/04/2001US6326396 Glucose and lipid lowering compounds
12/04/2001US6326395 Amidine or amide substituted furan derivatives
12/04/2001US6326392 Anti-estrogen plus progestin containing oral contraceptives
12/04/2001US6326391 Inhibitors of multidrug transporters
12/04/2001US6326390 Use of adenosine A3 receptor antagonists to inhibit tumor growth
12/04/2001US6326389 Administering sodium channel modulators
12/04/2001US6326388 Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level
12/04/2001US6326387 Methods and compositions for stimulating neurite growth
12/04/2001US6326386 Anticoagulant
12/04/2001US6326385 Administering poltassium channel modulator
12/04/2001US6326384 Dry blend pharmaceutical unit dosage form
12/04/2001US6326383 Emesis therapy
12/04/2001US6326382 Cholinesterase inhibitors; useful in enhancing memory in patients suffering from dementia and alzheimer's disease
12/04/2001US6326379 Fused pyridine inhibitors of cGMP phosphodiesterase
12/04/2001US6326378 Use of thiadiazolo[4,3-a]pyridine derivatives
12/04/2001US6326377 Psychological disorders therapy
12/04/2001US6326376 Anhydrovinblastine for the treatment of cancer
12/04/2001US6326375 Containing an urea group
12/04/2001US6326374 Analgesics; containing gamma aminobutyric acid
12/04/2001US6326373 JAK-3 inhibitors for treating allergic disorders
12/04/2001US6326371 Pyrudyl and pyrimidylpiperazine derivatives
12/04/2001US6326370 Use of agonists or antagonists of P2 purinoceptors for the prevention of glutamate-evoked cytotoxicity
12/04/2001US6326368 Psychological disorders
12/04/2001US6326367 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
12/04/2001US6326366 Mixture of estrogen and isoflavone
12/04/2001US6326365 Methods of prevention and treatment of ischemic damage
12/04/2001US6326364 Use of 5-aminosalicylates as antimicrobial agents
12/04/2001US6326363 Methylenebisphosphonic acid derivatives
12/04/2001US6326362 (-)-phosphonorisperidone and (-)-sulforisperidone compositions and methods
12/04/2001US6326361 Gangliosides with immunosuppressive activity
12/04/2001US6326359 Adenosine A2A receptor agonists as antiinflammatory agents
12/04/2001US6326357 Bacterial cell complex composition and method of use
12/04/2001US6326356 Antitumor agents
12/04/2001US6326355 Method for the prevention and treatment of cachexia and anorexia
12/04/2001US6326353 123therapy for septic shock; administering polymyxin by injection
12/04/2001US6326205 Methods for use of Mpl ligands with primitive human stem cells
12/04/2001US6326201 Isolating stem cells of pancreas; obtain pancreatic tissue, dissociate and obtain pancreatic duct tissue, culture, isolate stem cells cells
12/04/2001US6326199 Hybridization and rnace activation in a cell with oligonucleotides
12/04/2001US6326195 Recombinant retroviral vector